Valo to participate in Morgan Stanley, Putting the Tech in Biotech: Exploring the World of Tech-Enabled Drug Development June 28, 2022
Valo to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence March 18, 2021 • Valo Health
Valo Health Receives $110 Million in Funding From Koch Disruptive Technologies to Close Series B March 9, 2021 • Valo Health
Valo Health to Participate in Barclays and Oppenheimer Healthcare Investor Conferences March 1, 2021 • Jennifer Hanley
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference January 11, 2021 • Jennifer Hanley